Objectives: To review the current literature and develop consensus conclusions and
recommendations on nutrient intakes and nutritional practice in preterm infants with …

Parenteral nutrition (PN) is a common therapy for preterm, very low birthweight (VLBW;
birthweight< 1500 g), and other high-risk newborns. PN is required for the period when …

Background & aims Nutrition is a cornerstone of postnatal care to prevent compromised
growth and support short-and long-term health outcomes in preterm infants. We aimed to …

Parenteral nutrition (PN) is recognized as a complex high-risk therapy. Its practice is highly
variable and frequently suboptimal in pediatric patients. Optimizing care requires evidence …

Objectives: This study aimed to investigate the effects of a higher intake of electrolytes from
parenteral nutrition (PN) on plasma electrolyte concentrations in very low birth weight …

Very low birthweight (VLBW,< 1500 g) infants may be predisposed to undernutrition during
the nutritional transition phase from parenteral to enteral nutrition. We studied the …

The safety of parenteral nutrition (PN) remains a concern in preterm neonates, impacting
clinical outcomes and health-care-resource use and costs. This cost-consequence analysis …

Aim We evaluated the nutrient intakes of very low birthweight (VLBW) infants weighing less
than 1500 g and tested the hypothesis that using a triple‐chamber parenteral nutrition (PN) …

Aim There has been a lack of population‐based longitudinal data on serum ferritin in very
low birthweight (VLBW) infants during hospitalisation. Our aim was to fill this gap in the …

Objectives: Hypermagnesemia has been reported in preterm neonates treated with
commercial pediatric triple-chamber bag (3CB) parenteral nutrition (PN). This postmarketing …